Anika Therapeutics, Inc. Quarterly Amortization of Intangible Assets in USD from Q2 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Anika Therapeutics, Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from Q2 2011 to Q3 2024.
  • Anika Therapeutics, Inc. Amortization of Intangible Assets for the quarter ending September 30, 2024 was $300K, a 84.2% decline year-over-year.
  • Anika Therapeutics, Inc. Amortization of Intangible Assets for the twelve months ending September 30, 2024 was $3M, a 62% decline year-over-year.
  • Anika Therapeutics, Inc. annual Amortization of Intangible Assets for 2023 was $7.8M, unchanged from 2022.
  • Anika Therapeutics, Inc. annual Amortization of Intangible Assets for 2022 was $7.8M, unchanged from 2021.
  • Anika Therapeutics, Inc. annual Amortization of Intangible Assets for 2021 was $7.8M, a 5.41% increase from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $3M $300K -$1.6M -84.2% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-04
Q2 2024 $4.6M $400K -$1.6M -80% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $6.2M $300K -$1.6M -84.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $7.8M $2M -$100K -4.76% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-15
Q3 2023 $7.9M $1.9M $0 0% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-04
Q2 2023 $7.9M $2M +$100K +5.26% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $7.8M $1.9M $0 0% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $7.8M $2.1M +$200K +10.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-15
Q3 2022 $7.6M $1.9M -$100K -5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 $7.7M $1.9M -$100K -5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $7.8M $1.9M $0 0% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $7.8M $1.9M -$100K -5% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-15
Q3 2021 $7.9M $2M +$100K +5.26% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $7.8M $2M -$200K -9.09% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $8M $1.9M +$600K +46.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $7.4M $2M +$1.8M +900% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-11
Q3 2020 $5.6M $1.9M +$1.6M +533% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $4M $2.2M +$2M +1000% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $2M $1.3M +$1M +333% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $1M $200K $0 0% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-11
Q3 2019 $1M $300K +$100K +50% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $900K $200K -$100K -33.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 $1M $300K $0 0% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-22
Q4 2018 $1M $200K -$200K -50% Oct 1, 2018 Dec 31, 2018 10-K/A 2021-04-26
Q3 2018 $1.2M $200K $0 0% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-28
Q2 2018 $1.2M $300K +$100K +50% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-26
Q1 2018 $1.1M $300K +$100K +50% Jan 1, 2018 Mar 31, 2018 10-Q 2018-05-10
Q4 2017 $1M $400K +$200K +100% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-06
Q3 2017 $800K $200K -$100K -33.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-26
Q2 2017 $900K $200K -$100K -33.3% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-31
Q1 2017 $1M $200K -$100K -33.3% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $1.1M $200K $0 0% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-27
Q3 2016 $1.1M $300K $0 0% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-27
Q2 2016 $1.1M $300K $0 0% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-28
Q1 2016 $1.1M $300K $0 0% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 $1.1M $200K -$307K -60.5% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-27
Q3 2015 $1.41M $300K -$219K -42.2% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-01
Q2 2015 $1.63M $300K -$236K -44.1% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-01
Q1 2015 $1.86M $300K -$238K -44.3% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-03
Q4 2014 $2.1M $507K -$37.5K -6.89% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-24
Q3 2014 $2.14M $519K -$2.69K -0.52% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-03
Q2 2014 $2.14M $536K +$21.8K +4.24% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-04
Q1 2014 $2.12M $538K +$18.4K +3.53% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-04
Q4 2013 $2.1M $544K Oct 1, 2013 Dec 31, 2013 10-K 2016-03-10
Q3 2013 $521K +$27.1K +5.48% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 $514K +$7.72K +1.52% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-04
Q1 2013 $520K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-05
Q3 2012 $494K -$53.1K -9.71% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-05
Q2 2012 $507K -$38.1K -6.99% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-06
Q3 2011 $547K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-08
Q2 2011 $545K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.